Chromocell Therapeutics Corporation (CHRO)

USD 0.59

(-4.76%)

Revenue Summary of Chromocell Therapeutics Corporation

  • Chromocell Therapeutics Corporation's latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Chromocell Therapeutics Corporation's latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Chromocell Therapeutics Corporation reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Chromocell Therapeutics Corporation reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • Chromocell Therapeutics Corporation reported a quarterly revenue of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Chromocell Therapeutics Corporation reported a quarterly revenue of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of Chromocell Therapeutics Corporation (2023 - 2020)

Historical Annual Revenue of Chromocell Therapeutics Corporation (2023 - 2020)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 199.93 Thousand USD 0.0%

Peer Revenue Comparison of Chromocell Therapeutics Corporation

Name Revenue Revenue Difference
AIM ImmunoTech Inc. 202 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Armata Pharmaceuticals, Inc. 4.52 Million USD 100.0%
Actinium Pharmaceuticals, Inc. 81 Thousand USD 100.0%
Azitra, Inc. 686 Thousand USD 100.0%
Can-Fite BioPharma Ltd. 743 Thousand USD 100.0%
Calidi Biotherapeutics, Inc. - USD NaN%
CEL-SCI Corporation - USD NaN%
iBio, Inc. 225 Thousand USD 100.0%
Lineage Cell Therapeutics, Inc. 8.94 Million USD 100.0%
MAIA Biotechnology, Inc. - USD NaN%
Matinas BioPharma Holdings, Inc. 1.09 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD 100.0%
NovaBay Pharmaceuticals, Inc. 14.72 Million USD 100.0%
NanoViricides, Inc. - USD NaN%
Oragenics, Inc. 37.65 Thousand USD 100.0%
BiomX Inc. -357 Thousand USD 100.0%
BiomX Inc. -357 Thousand USD 100.0%
Protalix BioTherapeutics, Inc. 65.49 Million USD 100.0%
Palatin Technologies, Inc. 4.49 Million USD 100.0%
Scorpius Holdings, Inc. 6.99 Million USD 100.0%